12 March 2010
Over 1,300 doctors have made their nominations for the PharmaTimes Representative of the Year 2010 event, with AstraZeneca’s staff leading the way.
Some 1,340 doctors have voted for their favourite primary and secondary care reps from over 100 pharmaceutical companies and 50 of the latter attracted three or more nominations. Organised by Doctors.net for PharmaTimes, the most nominated company across primary and secondary care was
- AstraZeneca, followed by
- Pfizer,
- GlaxoSmithKline,
- Eli Lilly and
- Merck Sharp & Dohme.
In general practice,
- Pfizer was the most nominated company, followed by
- AstraZeneca,
- MSD and
- GSK, with
- Boehringer Ingelheim and Napp in joint fifth place.
In secondary care, the most nominations received were in the mental health category, headed up by AstraZeneca, followed by Lilly and Johnson & Johnson’s Janssen-Cilag unit.
No hay comentarios:
Publicar un comentario